Stockholm, February 15 2013 — NASDAQ OMX (NASDAQ: NDAQ) announces that the trading in Vigmed Holding AB (short name: VIG) shares will commence today on First North at NASDAQ OMX Stockholm. Vigmed belongs to the Healthcare sector and is the second company to be admitted to trading on First North in 2013.

Vigmed is a Swedish Medical Device Company focused on developing cost-effective and safe solutions for preventing needle stick injuries in healthcare, e.g., IV-cannula, syringes, blood collection needles and lancets. The company’s patented technology is designed to offer optimum safety without hampering operator precision and compliance.

“Through our listing at First North we are able to further capitalize Vigmed’s core business in order to support continued expansion,” said Vigmed’s CEO Mr. Finn Ketler. “We have a long-term business plan that we believe will benefit from the transparent environment that a public listing offers by allowing us grow the ownership-base and build value over time.”

“It is rewarding to see yet another innovative Swedish company join First North and we welcome Vigmed to the NASDAQ OMX family of companies,” said Emelie Jarnesten, head of NASDAQ OMX First North. “In spite of a European slowdown in listings First North continues to attract entrepreneurial companies with the ambition to leverage the unique investor exposure advantages of a publicly traded environment.”

Vigmed Holding AB has appointed Remium Nordic AB as Certified Adviser.

- # -

About First North
First North is regulated as a multilateral trading facility, operated by the different exchanges within NASDAQ OMX Nordic. It does not have the legal status as an EU-regulated market. Companies at First North are subject to the rules of First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market.
 

About NASDAQ OMX
The inventor of the electronic exchange, The NASDAQ OMX Group, Inc., fuels economies and provides transformative technologies for the entire lifecycle of a trade - from risk management to trade to surveillance to clearing. In the U.S. and Europe, we own and operate 26 markets including 3 clearinghouses and 5 central securities depositories supporting equities, options, fixed income, derivatives, commodities, futures and structured products. Able to process more than 1 million messages per second at sub-55 microsecond average speeds with 99.99% uptime, our technology drives more than 70 marketplaces in 50 developed and emerging countries into the future, powering 1 in 10 of the world’s securities transactions. Our award-winning data products and worldwide indexes are the benchmarks in the financial industry. Home to approximately 3,300 listed companies worth $6 trillion in market cap whose innovations shape our world, we give the ideas of tomorrow access to capital today. Welcome to where the world takes a big leap forward, daily. Welcome to the NASDAQ OMX Century.

To learn more, visit www.nasdaqomx.com. Follow us on Facebook (http://www.facebook.com/NASDAQ) and Twitter (http://www.twitter.com/nasdaqomx). (Symbol: NDAQ and member of S&P 500)

 
Cautionary Note Regarding Forward-Looking Statements

The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about NASDAQ OMX's products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond NASDAQ OMX's control. These factors include, but are not limited to factors detailed in NASDAQ OMX's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.

Media contact:
Carl Norell
+46 8 405 66 39
carl.norell@nasdaqomx.com